Structure, heterogeneity and developability assessment of therapeutic antibodies

Increasing attention has been paid to developability assessment with the understanding that thorough evaluation of monoclonal antibody lead candidates at an early stage can avoid delays during late-stage development. The concept of developability is based on the knowledge gained from the successful...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:MAbs
Auteurs principaux: Xu, Yingda, Wang, Dongdong, Mason, Bruce, Rossomando, Tony, Li, Ning, Liu, Dingjiang, Cheung, Jason K, Xu, Wei, Raghava, Smita, Katiyar, Amit, Nowak, Christine, Xiang, Tao, Dong, Diane D., Sun, Joanne, Beck, Alain, Liu, Hongcheng
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380400/
https://ncbi.nlm.nih.gov/pubmed/30543482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1553476
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires